Influx Healthtech Limited (NSEI: INFLUX)
Health Care · Life Sciences Tools & Services · IN
Rs270.35
+5.61% today · +53.0% 1Y
Influx Healthtech Limited (NSEI: INFLUX) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $64.67M.
Over the last twelve months the share price has gained 53.0%, trading between 166.00 and 315.00.
Tweenvest scores Influx Healthtech Limited across four factors: quality 85/100, value 45/100. Its strongest factor is quality.
INFLUX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $64.67M
- Revenue (TTM)
- $15.66M
- P/E
- 28.92
- EPS
- 9.35
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- Rs315.00
- 52-week low
- Rs166.00
- Avg volume (3M)
- —
- Shares outstanding
- 23.15M
- Employees
- —
- Next earnings
- —
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| DreamCIS, Inc.KOSDAQ: A223250 | $71.00M | ₩3,880.00 | +0.13% |
| MindWalk Holdings Corp.NasdaqCM: HYFT | $70.43M | $1.42 | -5.02% |
| Xlife Sciences AGSWX: XLS | $68.02M | CHF9.80 | -4.85% |
| Champions Oncology, Inc.NasdaqCM: CSBR | $67.37M | $4.80 | -0.83% |
| Immuno-Biological Laboratories Co., Ltd.TSE: 4570 | $63.05M | ¥1,072.00 | -6.38% |
| Fabtech Technologies LimitedNSEI: FABTECH | $61.19M | Rs133.22 | -6.19% |
| Pangaea Oncology, S.A.BME: PANG | $57.50M | €1.43 | 0.00% |
| Circle8 Group, Inc.NasdaqGM: CIRC | $55.22M | $0.45 | -7.81% |
Figures last refreshed Oct 11, 2026.